Expression of proteoglycans in two types of ameloblastoma: novel Immunohistochemical findings.
ZAIRA GOMEZ-HERRERA, Ronell Bologna‐Molina(Universidad de la República de Uruguay), José Eduardo Farfán-Morales(Instituto Nacional de Pediatria), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana), Pablo Damián‐Matsumura(Universidad Autónoma Metropolitana), Rogelio González‐González(Universidad de la República de Uruguay)
PubMed
August 14, 2018
Cited by 0
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58